Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Early-onset epilepsy tied to lower academic achievement

18

Aug 2026

Early-onset epilepsy tied to lower academic achievement

Childhood epilepsy is linked to significantly poorer exam grades and long term educational attainment, with the lowest levels of academic prowess among those whose neurological disorder started when they were very young, finds a large, long term Danish study, published online in the Journal of Neurology Neurosurgery & Psychiatry.

Leisure-time exercise linked to lower dementia risk

18

Aug 2026

Leisure-time exercise linked to lower dementia risk

For years, scientists have known that regular physical activity can help lower the risk of dementia. But new USC research suggests that it's not only the amount but also the activity's context - for work or for leisure - that makes a difference.

Multiple long-term conditions raise pregnancy risks, study finds

18

Aug 2026

Multiple long-term conditions raise pregnancy risks, study finds

Women who begin pregnancy with two or more pre-existing, long-term physical or mental health conditions have 20% higher risk of miscarriage, 69% higher risk of severe nausea and vomiting, and around four times the risk of anxiety and depression, compared with those with no long-term conditions.

Paying attention to your body may change how an acute skin inflammation unfolds

18

Aug 2026

Paying attention to your body may change how an acute skin inflammation unfolds

Voluntary attention to inflammation-related bodily sensations reduced the magnitude of histamine-induced skin inflammation and promoted faster resolution compared with distraction in healthy adults. The findings point to complementary sensory-dependent and top-down autonomic pathways, although the precise neural and immune mechanisms remain unresolved.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.